Cited by 105Cutaneous lymphoproliferative disorders researchLymphoma Diagnosis and TreatmentCancer and Skin Lesions

Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas

Open access
Daniels, Jay, Doukas, Peter G., Escala, Maria E. Martinez, Ringbloom, Kimberly G., Shih, David J. H., Yang, Jingyi, Tegtmeyer, Kyle, Park, Joonhee +16 more·2020·Nature Communications

Abstract

Primary cutaneous γδ T cell lymphomas (PCGDTLs) represent a heterogeneous group of uncommon but aggressive cancers. Herein, we perform genome-wide DNA, RNA, and T cell receptor (TCR) sequencing on 29 cutaneous γδ lymphomas. We find that PCGDTLs are not uniformly derived from Vδ2 cells. Instead, the cell-of-origin depends on the tissue compartment from which the lymphomas are derived. Lymphomas arising from the outer layer of skin are derived from Vδ1 cells, the predominant γδ cell in the epidermis and dermis. In contrast, panniculitic lymphomas arise from Vδ2 cells, the predominant γδ T cell in the fat. We also show that TCR chain usage is non-random, suggesting common antigens for Vδ1 and Vδ2 lymphomas respectively. In addition, Vδ1 and Vδ2 PCGDTLs harbor similar genomic landscapes with potentially targetable oncogenic mutations in the JAK/STAT, MAPK, MYC, and chromatin modification pathways. Collectively, these findings suggest a paradigm for classifying, staging, and treating these diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-15572-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-17 release by DETCs can promote DNA repair following exposure to UV radiation and protect the skin against potential opportunistic infections by releasing keratinocyte-derived antimicrobial peptides.

    “IL-17 release by DETCs can promote DNA repair following exposure to UV radiation and protect the skin against potential opportunistic infections by releasing keratinocyte-derived antimicrobial peptides (37, 38).”

    From Comparing Mouse and Human Tissue-Resident γδ T Cells (2022) · cites this paper as [38]

    The Discussion (page not provided) says that, in mouse models, γδ T cells protect against microbes and contribute to epidermal homeostasis. It does not say that DETC-derived IL-17 promotes DNA repair after UV exposure or that keratinocyte-derived antimicrobial peptides provide the claimed protection. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 74

  1. [1]Foppoli M Ferreri AJM Gamma-delta t-cell lymphomas Eur. J. Haematol. 2014 94 206 218 10.1111/ejh.12439 25154298 · DOI
  2. [2]Guitart J Cutaneous γδ T-cell Lymphomas Am. J. Surg. Pathol. 2012 36 1656 1665 10.1097/PAS.0b013e31826a5038 23073324 · DOI
  3. [3]Gibson JF Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma J. Am. Acad. Dermatol. 2015 72 1010 1015.e1015 10.1016/j.jaad.2015.01.003 25981001 · DOI
  4. [4]Merrill ED Primary cutaneous T-cell lymphomas showing Gamma-Delta (γδ) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous γδ T-Cell lymphomas Am. J. Surg. Pathol. 2017 41 204 215 10.1097/PAS.0000000000000768 27879514 · DOI
  5. [5]Chien Y-h Meyer C Bonneville M γδT cells: first line of defense and beyond Annu. Rev. Immunol. 2014 32 121 155 10.1146/annurev-immunol-032713-120216 24387714 · DOI
  6. [6]Silva-Santos B Serre K Norell H γδ T cells in cancer Nat. Rev. Immunol. 2015 15 683 691 10.1038/nri3904 26449179 · DOI · Paper page
  7. [7]Girardi M Immunosurveillance and Immunoregulation by γδ T Cells J. Investig. Dermatol. 2006 126 25 31 10.1038/sj.jid.5700003 16417214 · DOI
  8. [8]Wu D Wu P Qiu F Wei Q Huang J Human γδT-cell subsets and their involvement in tumor immunity Cell Mol Immunol 2016 14 245 253 10.1038/cmi.2016.55 27890919 PMC5360884 · DOI
  9. [9]Falini B Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues J. Immunol. 1989 143 2480 2477444
  10. [10]Groh V Recognition of stress-induced MHC molecules by intestinal epithelial T cells Science 1998 279 1737 1740 10.1126/science.279.5357.1737 9497295 · DOI
  11. [11]Moser B Eberl M γδ T cells: novel initiators of adaptive immunity Immunol. Rev. 2007 215 89 102 10.1111/j.1600-065X.2006.00472.x 17291281 · DOI
  12. [12]Przybylski GK Hepatosplenic and subcutaneous panniculitis-like γ/δ T cell lymphomas are derived from different Vδ subsets of γ/δ T lymphocytes J. Mol. Diagn. 2000 2 11 19 10.1016/S1525-1578(10)60610-1 11272897 PMC1906890 · DOI
  13. [13]Küçük C Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells Nat. Commun. 2015 6 6025 10.1038/ncomms7025 25586472 PMC7743911 · DOI
  14. [14]Bolotin DA MiXCR: software for comprehensive adaptive immunity profiling Nature Methods 2015 12 380 381 10.1038/nmeth.3364 25924071 · DOI
  15. [16]Gaulard, P. & De Leval, L. Pathology of peripheral T-cell lymphomas: where do we stand? Semin. Hematol.51, 5–16 (2014). 24468311
  16. [17]Alaibac M Molecular analysis of the gammadelta T-cell receptor repertoire in normal human skin and in oriental cutaneous leishmaniasis Exp Dermatol 1993 2 106 112 10.1111/j.1600-0625.1993.tb00017.x 8162326 · DOI
  17. [18]Love MI Huber W Anders S Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Genome Biol. 2014 15 550 10.1186/s13059-014-0550-8 25516281 PMC4302049 · DOI · Paper page
  18. [19]Gutierrez-Arcelus M Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions Nat. Commun. 2019 10 687 10.1038/s41467-019-08604-4 30737409 PMC6368609 · DOI
  19. [20]McCully ML CCR8 expression defines tissue-resident memory T cells in human skin J. Immunol. 2018 200 1639 1650 29427415 PMC5818732
  20. [21]The Gene Ontology Consortium. The gene ontology resource: 20 years and still GOing strong Nucleic Acids Res. 2019 47 D330 D338 10.1093/nar/gky1055 30395331 PMC6323945 · DOI · Paper page
  21. [23]Lachmann A ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments Bioinforma 2010 26 2438 2444 10.1093/bioinformatics/btq466 PMC2944209 20709693 · DOI
  22. [24]Kim YH Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome Arch Dermatol 2003 139 857 866 12873880
  23. [25]Arico M Danesino C Pende D Moretta L Pathogenesis of haemophagocytic lymphohistiocytosis Br. J. Haematol. 2001 114 761 769 10.1046/j.1365-2141.2001.02936.x 11564062 · DOI
  24. [26]Swerdlow SH Cytotoxic T-cell and NK-cell lymphomas Am. J. Surg. Pathol. 2014 38 e60 e71 10.1097/PAS.0000000000000295 25025449 PMC6329302 · DOI
  25. [27]Nielsen MM Witherden DA Havran WL γδ T cells in homeostasis and host defence of epithelial barrier tissues Nat. Rev. Immunol. 2017 17 733 745 10.1038/nri.2017.101 28920588 PMC5771804 · DOI · Paper page
  26. [28]Uldrich AP CD1d-lipid antigen recognition by the γδ TCR Nat. Immunol. 2013 14 1137 1145 10.1038/ni.2713 24076636 · DOI
  27. [29]Gerlini G CD1d is expressed on dermal dendritic cells and monocyte-derived dendritic Cells 2001 117 576 582 11564162
  28. [30]Bethune MT Domain-swapped T cell receptors improve the safety of TCR gene therapy Elife 2016 5 e19095 10.7554/eLife.19095 27823582 PMC5101000 · DOI
  29. [31]Torres-García W PRADA: pipeline for RNA sequencing data analysis Bioinformatics 2014 30 2224 2226 10.1093/bioinformatics/btu169 24695405 PMC4103589 · DOI
  30. [32]Bos JL ras Oncogenes in human cancer: a review Cancer Res. 1989 49 4682 4689 2547513
  31. [33]Schmidt G Biochemical and biological consequences of changing the specificity of p21ras from guanosine to xanthosine nucleotides Oncogene 1996 12 87 96 8552403
  32. [35]Koskela HLM Somatic STAT3 mutations in large granular lymphocytic Leukemia 2012 366 1905 1913 PMC3693860 22591296
  33. [36]McKinney M The genetic basis of hepatosplenic T-cell lymphoma Cancer Discov. 2017 7 369 379 10.1158/2159-8290.CD-16-0330 28122867 PMC5402251 · DOI
  34. [37]Degryse S JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model Blood 2014 124 3092 3100 10.1182/blood-2014-04-566687 25193870 · DOI
  35. [38]Huang FW Highly recurrent TERT promoter mutations in human melanoma Science 2013 339 957 959 10.1126/science.1229259 23348506 PMC4423787 · DOI · Paper page
  36. [39]Mermel CH GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers Genome Biology 2011 12 R41 10.1186/gb-2011-12-4-r41 21527027 PMC3218867 · DOI
  37. [40]Ungewickell A Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2 Nat. Genet. 2015 47 1056 1060 10.1038/ng.3370 26258847 PMC6091217 · DOI
  38. [41]Gao X Gao C Liu G Hu J MAP4K4: an emerging therapeutic target in cancer Cell Biosci 2016 6 56 10.1186/s13578-016-0121-7 27800153 PMC5084373 · DOI
  39. [42]Shen L Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma Am J Pathol 2002 161 2123 2131 10.1016/S0002-9440(10)64490-2 12466128 PMC1850920 · DOI
  40. [43]Wartewig T PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis Nature 2017 552 121 125 10.1038/nature24649 29143824 PMC5821214 · DOI
  41. [44]Kiessling MK High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade Blood 2011 117 2433 2440 10.1182/blood-2010-09-305128 21209378 PMC3952811 · DOI
  42. [45]Laharanne E CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma Mod. Pathol. 2010 23 547 558 10.1038/modpathol.2009.196 20118908 · DOI
  43. [46]Chakravarty D OncoKB: a precision oncology knowledge base JCO Precis. Oncol. 2017 1 1 16 PMC5586540 28890946
  44. [47]Dummer R Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial Lancet Oncol 2017 18 435 445 10.1016/S1470-2045(17)30180-8 28284557 · DOI
  45. [48]Tolcher AW Antitumor activity in RAS-driven tumors by blocking AKT and MEK Clin Cancer Res 2015 21 739 748 10.1158/1078-0432.CCR-14-1901 25516890 PMC4335074 · DOI
  46. [49]Gayden T Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome Nat. Genet. 2018 50 1650 1657 10.1038/s41588-018-0251-4 30374066 · DOI
  47. [50]Moffitt AB Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2 J. Exp. Med. 2017 214 1371 1386 10.1084/jem.20160894 28424246 PMC5413324 · DOI
  48. [51]Lima M Non-cytotoxic gamma-delta peripheral T-cell lymphoma affecting the mandibular and parotidal lymph nodes and the skin Leuk. Lymphoma 2003 44 525 529 10.1080/1042819021000035626 12688326 · DOI
  49. [52]Prencipe G Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome J. Allergy Clin. Immunol. 2018 141 1439 1449 10.1016/j.jaci.2017.07.021 28807602 · DOI
  50. [53]Davey MS The human Vδ2(+) T-cell compartment comprises distinct innate-like Vγ9(+) and adaptive Vγ9(−) subsets Nat. Commun. 2018 9 1760 1760 10.1038/s41467-018-04076-0 29720665 PMC5932074 · DOI
  51. [54]Hunter S Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations J. Hepatol. 2018 69 654 665 10.1016/j.jhep.2018.05.007 29758330 PMC6089840 · DOI
  52. [55]Bruder J Target specificity of an autoreactive pathogenic human-T cell receptor in myositis J Biol Chem 2012 287 20986 20995 10.1074/jbc.M112.356709 22549773 PMC3375522 · DOI
  53. [56]Willcox CR Butyrophilin-like 3 directly binds a human Vγ4(+) T cell receptor using a modality distinct from clonally-restricted antigen Immunity 2019 51 813 825.e814 10.1016/j.immuni.2019.09.006 31628053 PMC6868513 · DOI
  54. [57]Agata Y Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes Int. Immunol. 1996 8 765 772 10.1093/intimm/8.5.765 8671665 · DOI · Paper page
  55. [58]Bachy E CD1d-restricted peripheral T cell lymphoma in mice and humans J Exp Med 2016 213 841 857 10.1084/jem.20150794 27069116 PMC4854725 · DOI
  56. [60]Jungbluth, A. A. et al. Immunohistochemical detection of γ/δ T lymphocytes in formalin-fixed paraffin-embedded tissues. Appl. Immunohistochem. Mol. Morphol. 27, 581–583 (2019). PMC7790162 29517505
  57. [61]Garcia-Herrera A Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation Am. J. Surg. Pathol. 2011 35 1214 1225 10.1097/PAS.0b013e31822067d1 21753698 PMC3136885 · DOI
  58. [62]Li H Durbin R Fast and accurate short read alignment with Burrows–Wheeler transform Bioinformatics 2009 25 1754 1760 10.1093/bioinformatics/btp324 19451168 PMC2705234 · DOI · Paper page
  59. [63]Cibulskis K Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples Nat. Biotechnol. 2013 31 213 219 10.1038/nbt.2514 23396013 PMC3833702 · DOI
  60. [64]Park J Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E) Blood 2017 130 1430 1440 10.1182/blood-2017-02-768234 28694326 PMC5609333 · DOI
  61. [65]Diossy, M. et al. Strand Orientation Bias Detector (SOBDetector) to remove artifacts from sequencing data of formalin fixed samples. Preprint at 10.1101/386417 (2018). · DOI
  62. [66]McKenna A The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res. 2010 20 1297 1303 10.1101/gr.107524.110 20644199 PMC2928508 · DOI · Paper page
  63. [67]Mayrhofer M Dilorenzo S Isaksson A Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue Genome Biol 2013 14 R24 10.1186/gb-2013-14-3-r24 23531354 PMC4053982 · DOI
  64. [68]Prandi D Unraveling the clonal hierarchy of somatic genomic aberrations Genome Biol. 2014 15 439 10.1186/s13059-014-0439-6 25160065 PMC4167267 · DOI
  65. [69]Díaz-Gay M Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples BMC Bioinform. 2018 19 224 10.1186/s12859-018-2234-y PMC6001047 29898651 · DOI
  66. [70]Dobin A STAR: ultrafast universal RNA-seq aligner Bioinformatics 2013 29 15 21 10.1093/bioinformatics/bts635 23104886 PMC3530905 · DOI · Paper page
  67. [71]Anders S Pyl PT Huber W HTSeq—a Python framework to work with high-throughput sequencing data Bioinformatics 2015 31 166 169 10.1093/bioinformatics/btu638 25260700 PMC4287950 · DOI · Paper page
  68. [72]Pertea M Kim D Pertea GM Leek JT Salzberg SL Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown Nat. Protoc. 2016 11 1650 1667 10.1038/nprot.2016.095 27560171 PMC5032908 · DOI
  69. [73]Long AH 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors Nat. Med. 2015 21 581 590 10.1038/nm.3838 25939063 PMC4458184 · DOI · Paper page
  70. [74]Webb B Sali A Comparative protein structure modeling using MODELLER Curr. Protoc. Bioinforma. 2016 54 5.6.1 5.6.37 10.1002/cpbi.3 PMC5031415 27322406 · DOI
  71. [75]Pierce BJ Weng Z A flexible docking approach for prediction of T cell receptor–peptide–MHC complexes Protein Sci 2013 22 35 46 10.1002/pro.2181 23109003 PMC3575858 · DOI
  72. [76]Leaver-Fay, A. et al. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol.487, 545–574 (2011). PMC4083816 21187238
  73. [77]Pierce BG Vreven T Weng Z Modeling T cell receptor recognition of CD1-lipid and MR1-metabolite complexes BMC Bioinform 2014 15 319 10.1186/1471-2105-15-319 PMC4261541 25260513 · DOI
  74. [78]Alford RF The rosetta all-atom energy function for macromolecular modeling and design J. Chem. Theory Comput. 2017 13 3031 3048 10.1021/acs.jctc.7b00125 28430426 PMC5717763 · DOI · Paper page

Cited by

Sorted by citations

Authors
Daniels, J., Doukas, P. G., Escala, M. E. M., Ringbloom, K. G., Shih, D. J. H., Yang, J., Tegtmeyer, K., Park, J., Thomas, J. J., Selli, M. E., Altunbulakli, C., Gowthaman, R., Mo, S. H., Jothishankar, B., Pease, D. R., Pro, B., Abdulla, F. R., Shea, C., Sahni, N., Gru, A. A., Pierce, B. G., Louissaint, A., Guitart, J., & Choi, J.
Affiliations
  • Northwestern University (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Institute for Bioscience and Biotechnology Research (US)
  • University of Illinois Chicago (US)
  • University of Chicago (US)
  • City Of Hope National Medical Center (US)
  • University of Virginia Health System (US)
  • Massachusetts General Hospital (US)
Corresponding author
  • Louissaint, Abner
  • Guitart, Joan
  • Choi, Jaehyuk
Venue
Nature Communications
Published
2020-04-14
Volume
11
Issue
1
Pages
1806-1806
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3016153237
Cited by
105
References
4
Citations by year
2026: 7 · 2025: 14 · 2024: 19 · 2023: 22 · 2022: 18 · 2021: 20 · 2020: 4
FWCI
11.68
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32 CA009560, K08-CA191019-01A1)
  • U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T35DK062719-29)
  • Cancer Prevention and Research Institute of Texas (RR160021)
  • Alfred P. Sloan Foundation (FG-2018-10723)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01 GM126299)
  • U.S. Department of Health & Human Services | National Institutes of Health (1DP2AI136599-01)
  • American Cancer Society (ACS-IRG-15-173-21)
  • Leukemia Research Foundation (n/a)
  • Damon Runyon Cancer Research Foundation (DRCRF# CI-84-16)
  • Doris Duke Charitable Foundation (DDCF# 2016095)
  • Skin Cancer Foundation (n/a)
Topics
  • Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Dermatology › Cancer and Skin Lesions
Keywords
primary cutaneous gamma-delta T-cell lymphoma, Vδ1 T cells, Vδ2 T cells, cell of origin, T cell receptor repertoire, genomic landscape, JAK/STAT signaling, MAPK signaling, c-Myc, chromatin modification, epidermis, dermis, skin fat
MeSH terms
Amino Acid Sequence, Epitopes, Humans, Lymph Nodes, Models, Biological, Mutation, Phenotype, Skin, Skin Neoplasms, Transcription, Genetic, Signal Transduction, Genome, Human, Lymphoma, T-Cell, Cutaneous, Receptors, Antigen, T-Cell, gamma-delta, Principal Component Analysis, Chromatin Assembly and Disassembly, Antigens, CD1d, HEK293 Cells, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review